1- Sackett DL. Compliance with therapeutic regimens. Baltimore: The John Hopkins University Press; 1979, p.1-6.
2- Briesacher BA, Andrade SE., Fouayzi H, Chan KA. Comparison of drug adherence rates among patients with seven different medical conditions. Pharmacotherapy. 2008; 28: 437–443.
3- Curtis JR, Xi J, Westfall AO, Cheng H, Lyles K, Saag KG, Delzell E. Improving the prediction of medication compliance: the example of bisphosphonates for osteoporosis. Med Care. 2009; 47:334–341.
4- Lawrence DB, Ragucci KR, Long DB, Parris BS, Helfer LA. Relationship of oral antihyperglycemic (sulfonylurea or met-formin) medication adherence and hemoglobin A1c goal attainment for HMO patients enrolled in a diabetes disease management pro-gram. J Manag Care Pharm 2006;12:466-71.
5- Ho PM Rumsfeld JS, Masoudi FA, McClure DL, Plomondon ME, Steiner JF, Magid DJ. Effect of medication non-adherence on hospitalization and mortality among patients with di-abetes mellitus. Arch Intern Med 2006; 166:1836-1841.
6- Lee WC, Balu S, Cbden D, Joshi AV, Pashos CL. Prevalence and economic consequences of medication adherence in diabetes: a systematic literature review. Manag Care Interface 2006; 19, 31–41.
7- World Health Organization Report. Sabaté, E., ed. Adherence to Long-Term Therapies, Evidence for Action, Geneva, Switzerland, 2003.
8- Reach G. The role of habit in the adherence to medical treatment. Diabetic Medicine, 2005; 22:415-20.
9- Park DC, Kidder DP. Prospective memory and medication adherence, In: Prospective Memory: Theory and Applications, Brandimonte M et al., eds, Lawrence Erlbaum Associates, 1996.
10- Reach G. Pourquoi se soigne-t-on, Enquête sur la rationalité morale de l’observance, Préface de Pascal Engel, Le Bord de l’Eau, 2007.
11- Livet P. Emotions et rationalité morale. Paris, P.U.F., Collection Sociologies; 2002.
12- Engel P. Les croyances. In : Notions de philosophie, sous la direction de D. Kambouchner, Editions Folio, Gallimard, 1995, p. 25.
13- Meichenbaum D Turk DC. Factors affecting adherence, In: Facilitating Treatment Adherence, Plenum Press, New York & London, 1987, p. 47.
14- Davidson D. Actions, reasons and causes. Journal of Philosophy. 1963. In : Essays on actions and events. Oxford: Clarendon Press; 2001. p. 3-19.
15- Reach G. Application de la théorie causale de l’action à l’analyse de la non-observance thérapeutique. Presse Médicale. 2000 ; 29, 1939-1946.
16- Story GW, Vlaev I, Seymour B, Darzi A, Dolan RJ. Does temporal discounting explain unhealthy behavior? A systematic review and reinforcement learning perspective. Front Behav Neurosci. 2014;8:76.
17- Parfit D. Reasons and persons. Oxford: Clarendon Press; 1984. p. 313-4.
18- Wamala S, Merlo J, Bostrom G, Hogstedt C, Agren G. Socioeconomic disadvantage and primary non-adherence with medication in Sweden. Int J Qual Health Care. 2007;19:134-40.
19- Girerd X, Hanon O, Anagnostopoulos K, Ciupek C, Mourad JJ, Consoli S. Evaluation de l’observance du traitement anti-hypertenseur par un questionnaire : mise au point et utilisation dans un service spécialisé. Presse Médicale. 2001; 30 : 1044-48
20- Reach G. Obedience and motivation as mechanisms for adherence to medication. A study in obese type 2 diabetic patients. Patient Prefer Adherence. 2011;5:523-31.
21- Fogarty JS, Youngs GA Jr. Psychological reactance as a factor in patient noncompliance with medication taking: a field experiment. J Appl Soc Psychol. 2000;30:2365–2391.
22- Barrier PA, Li JT, Jensen NM. Two words to improve physician-patient communication: what else? Mayo Clin Proc. 2003;78:211-4.
23- Reach G. Patient autonomy in chronic care: solving a paradox. Patient Prefer Adherence. 2013;8:15-24.
24- Safran DG, Taira DA, Rogers WH, Kosinski M, Ware JE, Tarlov AR. Linking primary care performance to outcomes of care. J Fam Pract. 1998;47:213-20.
Mise au point
Prise en charge de la goutte en 2025
Mise au point
Le prurit
Mise au point
Les infiltrations en médecine générale
Mise au point
Diagnostic de la maladie d’Alzheimer en 2025